Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylaxis against anthrax.

Miroslav Splino1, Jirí Patocka

  • 1Department of Epidemiology, Purkynĕ Military Medical Academy, Hradec Králové. splino@pmfhk.cz

Acta Medica (Hradec Kralove)
|January 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anticholinesterases Traits Inbuilt in <i>Buxaceae</i> Plant Extracts against Alzheimer's Disease.

Current neuropharmacology·2025
Same author

The psychostimulant drug, fenethylline (captagon): Health risks, addiction and the global impact of illicit trade.

Drug and alcohol dependence reports·2025
Same author

Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature.

Pharmaceuticals (Basel, Switzerland)·2025
Same author

Fentanyl and its derivatives: Pain-killers or man-killers?

Heliyon·2024
Same author

Dendrobine: A neuroprotective Sesquiterpenic Alkaloid for the Prevention and Treatment of Diseases: A Review.

Mini reviews in medicinal chemistry·2024
Same author

Health and Environmental Hazards of the Toxic <i>Pteridium aquilinum</i> (L.) Kuhn (Bracken Fern).

Plants (Basel, Switzerland)·2024
Same journal

Transient Occlusion of the Central Retinal Artery in a Patient with Granulomatosis with Polyangiitis.

Acta medica (Hradec Kralove)·2026
Same journal

Growth Hormone-Mediated Diabetic Ketoacidosis: A Rare Presentation of Acromegaly.

Acta medica (Hradec Kralove)·2026
Same journal

Comparison between the Prognosis of Temporomandibular Disorders with and without Accompanying Otologic Symptoms after Non-Invasive Non-Pharmacological Treatment: Controlled Clinical Trial.

Acta medica (Hradec Kralove)·2026
Same journal

Managing Impacted Mandibular Third Molars: A Scoping Review of Surgical Extraction versus Orthodontic Traction and Nerve Injury Risk.

Acta medica (Hradec Kralove)·2026
Same journal

Current and Emerging Approaches to Osseointegration Assessment in Dental Implantology: Limitations, Clinical Utility, and Future Directions.

Acta medica (Hradec Kralove)·2026
Same journal

Structural and Functional Determinants of Oxygen Transport in Exercise: The Role of Total Hemoglobin Mass.

Acta medica (Hradec Kralove)·2026
See all related articles

This paper details Bacillus anthracis, focusing on inhalation anthrax risks and the AVA vaccine. It covers vaccination, efficacy, adverse events, and crucial pre- and post-exposure prophylaxis strategies.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Biosecurity

Background:

  • Bacillus anthracis is a bacterium with potential for bioterrorism.
  • Anthrax infection, particularly inhalation anthrax, poses significant health risks.
  • Understanding B. anthracis is crucial for public health and security.

Purpose of the Study:

  • To provide fundamental knowledge on Bacillus anthracis.
  • To outline clinical forms of anthrax, emphasizing inhalation infection.
  • To review the AVA vaccine, its efficacy, and adverse events, alongside prophylaxis.

Main Methods:

  • Literature review of Bacillus anthracis.
  • Summary of clinical manifestations of anthrax.
  • Characterization of the AVA vaccine and its protective measures.

Related Experiment Videos

Main Results:

  • Inhalation anthrax is a primary concern due to spore inspiration.
  • The AVA vaccine demonstrates protective efficacy.
  • Adverse events associated with the AVA vaccine are documented.

Conclusions:

  • Comprehensive knowledge of B. anthracis is vital for counter-bioterrorism.
  • Effective prophylaxis, including vaccination and post-exposure measures, is essential.
  • The AVA vaccine is a key component in anthrax prevention and management.